[
  {
    "ts": "2025-11-13T14:01:19+00:00",
    "headline": "Is Bio-Techne Corporation (TECH) a High-Quality Growth-Oriented Compounder Within The Healthcare Sector?",
    "summary": "ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an environment of shifting monetary policy, stabilizing earnings, and improved sentiment, midcaps experienced growth in the third quarter. The Federal Reserve’s decision to cut rates helped small and mid-cap stocks […]",
    "url": "https://finance.yahoo.com/news/bio-techne-corporation-tech-high-140119546.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "cd96fb1b-2c8c-3286-b04e-9e9faf252033",
      "content": {
        "id": "cd96fb1b-2c8c-3286-b04e-9e9faf252033",
        "contentType": "STORY",
        "title": "Is Bio-Techne Corporation (TECH) a High-Quality Growth-Oriented Compounder Within The Healthcare Sector?",
        "description": "",
        "summary": "ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an environment of shifting monetary policy, stabilizing earnings, and improved sentiment, midcaps experienced growth in the third quarter. The Federal Reserve’s decision to cut rates helped small and mid-cap stocks […]",
        "pubDate": "2025-11-13T14:01:19Z",
        "displayTime": "2025-11-13T14:01:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/814b119681e323f3f9122b0b9de5fe4a",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "8 Most Promising Medical Stocks According to Hedge Funds",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DJ5oCGLm0mhsbvhPjHmL.g--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/814b119681e323f3f9122b0b9de5fe4a.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u1EoJbfQE6hhG5ieiEdLPQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/814b119681e323f3f9122b0b9de5fe4a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-corporation-tech-high-140119546.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-corporation-tech-high-140119546.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]